substance p has been researched along with Heart Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levick, SP | 1 |
| Agogo, GO; Guo, J; Peng, L; Yan, M | 1 |
| Chottova Dvorakova, M; Kruzliak, P; Mistrova, E | 1 |
| Chmielinska, JJ; Gonzalez, G; Mak, IT; Tejero-Taldo, MI; Weglicki, WB | 1 |
| Bian, JS; Hu, LF; Neo, KL; Pan, TT; Yong, QC | 1 |
| Brandes, RP; Haverich, A; Heublein, B; Lichtlen, PR; Mugge, A; Nolte, C | 1 |
| Landelius, J; Lundin, L; Norheim, I; Oberg, K; Theodorsson-Norheim, E | 1 |
2 review(s) available for substance p and Heart Diseases
| Article | Year |
|---|---|
Substance P and fibrotic diseases.
Topics: Animals; Corneal Diseases; Fibrosis; Heart Diseases; Humans; Inflammation; Joint Diseases; Kidney Diseases; Liver Cirrhosis; Primary Myelofibrosis; Substance P; Wound Healing | 2019 |
Role of substance P in the cardiovascular system.
Topics: Animals; Brain; Brain Ischemia; Cardiovascular Physiological Phenomena; Heart Diseases; Humans; Myocardial Ischemia; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Signal Transduction; Substance P | 2016 |
5 other study(ies) available for substance p and Heart Diseases
| Article | Year |
|---|---|
Understanding the Complex Roles of Substance P in the Diseased Heart.
Topics: Heart Diseases; Humans; Myocardium; Signal Transduction; Substance P; Ventricular Remodeling | 2018 |
N-methyl-D-aspartate receptor blockade inhibits cardiac inflammation in the Mg2+-deficient rat.
Topics: Animals; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Fluorescent Antibody Technique; Heart Diseases; Inflammation; Intercellular Adhesion Molecule-1; Magnesium Deficiency; Male; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Stress, Physiological; Substance P | 2004 |
Cyclooxygenase-2 mediates the delayed cardioprotection induced by hydrogen sulfide preconditioning in isolated rat cardiomyocytes.
Topics: Air Pollutants; Animals; Blotting, Western; Cell Separation; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Enzyme Inhibitors; Heart Diseases; Hydrogen Sulfide; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Janus Kinases; KATP Channels; Male; Myocardial Contraction; Myocytes, Cardiac; Protective Agents; Protein Kinase C; Rats; Rats, Sprague-Dawley; Signal Transduction; Substance P | 2008 |
Endothelial dysfunction in heart transplanted patients with graft vasculopathy.
Topics: Acetylcholine; Blood Flow Velocity; Coronary Vessels; Endothelium, Vascular; Heart Diseases; Heart Transplantation; Humans; Injections, Intra-Arterial; Nitroglycerin; Substance P; Vasculitis; Vasodilation; Vasodilator Agents | 1995 |
Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities.
Topics: Adult; Aged; Aged, 80 and over; Carcinoid Heart Disease; Female; Heart Diseases; Humans; Hydroxyindoleacetic Acid; Male; Malignant Carcinoid Syndrome; Middle Aged; Neuropeptides; Prospective Studies; Substance P; Tachykinins; Ultrasonography | 1988 |